January 26, 2011Open Access

Genomics and the Continuum of Cancer Care

Key Points

Key points are not available for this paper at this time.

Abstract

Microarray analysis, involving assay of the expression of thousands of genes, and systematic DNA sequencing have led to tools and medicines now used in the treatment of cancer. This article reviews recent progress in the genomic analysis of cancer.

Read Full Paperexternally

AIに質問

Bookmark

View Full Paper

Cite This Study

McDermott et al. (Wed,) studied this question.

synapsesocial.com/papers/6a1d59b0b1a9bd2ac02f1dee https://doi.org/https://doi.org/10.1056/nejmra0907178

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-023410662009 · 205 citations
2The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma2002 · 3,859 citations
3A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study2009 · 110 citations
4High Frequency of Mutations of the <i>PIK3CA</i> Gene in Human Cancers2004 · 3,435 citations
5The cancer genome2009 · 3,515 citations

AIに質問

Bookmark

View Full Paper